Skip to content

SoftWave Provider? Click here to learn more about SoftWaveClinics.com


Influence of extracorporeal shock wave therapy (ESWT) on bone turnover markers in organisms with normal and low bone mineral density during fracture healing: a randomized clinical trial

Influence of extracorporeal shock wave therapy (ESWT) on bone turnover markers in organisms with normal and low bone mineral density during fracture healing: a randomized clinical trial


Low bone mineral density (BMD) leads to metaphyseal fractures, which are considered of delayed, qualitatively reduced healing Christoph Wölfl 1 Laura Schuster2 resulting in prolonged care phases and increased socioeconomic costs. Bernd Höner3 Extracorporeal shockwave therapy (ESWT) is already approved to support Sarah Englert 1 bone healing of pseudarthrosis and delayed unions. With this study, we examined its influence on bone turnover markers (BTM) during fracture healing in patients with low and normal BMD​.

Click to read more.